BARISON, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3.116
EU - Europa 2.364
AS - Asia 307
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 7
AF - Africa 3
Totale 5.808
Nazione #
US - Stati Uniti d'America 2.989
GB - Regno Unito 656
IT - Italia 656
DE - Germania 390
UA - Ucraina 261
VN - Vietnam 130
CA - Canada 126
DK - Danimarca 117
CN - Cina 100
SE - Svezia 96
FR - Francia 68
IE - Irlanda 40
FI - Finlandia 36
HK - Hong Kong 34
SG - Singapore 15
PL - Polonia 14
EU - Europa 11
IN - India 8
RU - Federazione Russa 7
BD - Bangladesh 4
CH - Svizzera 4
IR - Iran 4
NL - Olanda 4
AR - Argentina 3
HR - Croazia 3
SM - San Marino 3
TH - Thailandia 3
CO - Colombia 2
GR - Grecia 2
JP - Giappone 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 5.808
Città #
Southend 444
Chandler 314
Houston 290
Fairfield 252
Ann Arbor 241
Woodbridge 224
San Mateo 200
Wilmington 137
Seattle 135
Cambridge 129
Falls Church 129
Dearborn 108
Jacksonville 107
Ashburn 98
Ottawa 97
Stevenage 79
Portsmouth 78
Dong Ket 68
Beijing 61
Pisa 59
Lawrence 57
Boardman 47
Dublin 38
Rome 36
San Diego 34
Milan 24
Brooklyn 22
Central District 21
Montréal 21
Redwood City 21
Dallas 15
Florence 15
London 14
Warsaw 12
Helsinki 11
Norwalk 11
Bari 10
Napoli 10
Old Bridge 10
Salerno 10
Fremont 9
Hong Kong 8
Palermo 8
Redmond 8
Bologna 7
Dongguan 6
Grammichele 6
Los Angeles 5
Padova 5
Pavia 5
Perugia 5
Reggio Calabria 5
Wandsworth 5
Acton 4
Augusta 4
Cascina 4
Chiswick 4
Lyon 4
Naples 4
Tehran 4
Agordo 3
Barletta 3
Chicago 3
Fabriano 3
Frankfurt am Main 3
Guangzhou 3
Honolulu 3
Hounslow 3
Lucca 3
Mountain View 3
Oristano 3
Paris 3
Serra 3
Toronto 3
Turin 3
Venice 3
Washington 3
Zagreb 3
Amsterdam 2
Basel 2
Berlin 2
Bratislava 2
Bucharest 2
Cagliari 2
Como 2
Cosenza 2
Faenza 2
Federal 2
Forlì 2
Hampton 2
Hanoi 2
Islington 2
Lachine 2
Lappeenranta 2
Livorno 2
Lucino 2
Lugano 2
Mariano Comense 2
Moscow 2
Mykolayiv 2
Totale 3.897
Nome #
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 561
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 215
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 167
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 167
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 166
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 165
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 156
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 151
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 149
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 148
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 147
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 146
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 145
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 144
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 143
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 142
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 142
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 141
Update sui biomarcatori nello scompenso cardiaco. 137
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 131
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 126
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 124
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 124
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 104
Sex-related differences in chronic heart failure 101
A simple echocardiographic score to rule out cardiac amyloidosis 83
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 82
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 82
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 78
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 76
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 73
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 70
Troponin in non-ischaemic dilated cardiomyopathy 65
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 62
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 60
Treatment of cardiac transthyretin amyloidosis: an update 57
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 54
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 46
Molecular autopsy of sudden cardiac death in the genomics era 46
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 45
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 45
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 45
Cardiovascular disease and COVID-19: les liaisons dangereuses 44
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 44
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 42
The Barthel Index in elderly acute heart failure patients. Frailty matters 41
Colchicine for the treatment of coronary artery disease 39
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 39
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 39
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 38
Role of Imaging in Cardiomyopathies 37
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 37
Cardiac magnetic resonance in patients with muscular dystrophies 35
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 35
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 30
The unbearable underreporting of comorbidities in heart failure clinical trials 30
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 30
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 29
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 28
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 28
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 26
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 23
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 22
A simple echocardiographic score to rule out cardiac amyloidosis 21
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 13
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 11
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 9
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 7
Partial Lipodystrophy and LMNA p.R545H Variant 6
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 6
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 6
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 5
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 5
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 4
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 4
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 2
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 2
Totale 5.928
Categoria #
all - tutte 32.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201929 0 0 0 0 0 0 0 0 0 0 10 19
2019/2020626 24 32 41 49 81 102 98 21 61 21 23 73
2020/20211.519 110 120 54 114 96 179 136 74 160 112 171 193
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024407 41 18 107 57 22 51 48 23 12 14 14 0
Totale 5.928